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 Interictal source imaging studies are biased and show heterogeneity for population and test method.
 Source imaging sensitivity and specificity was 82% (95% CI: 75–88%) and 53% (37–68%) respectively.
 Diagnostic accuracy for (extra)temporal and (non)-lesional patients show no statistical differences.
a b s t r a c t
Objective: Interictal high resolution (HR-) electric source imaging (ESI) and magnetic source imaging
(MSI) are non-invasive tools to aid epileptogenic zone localization in epilepsy surgery candidates. We car-
ried out a systematic review on the diagnostic accuracy and quality of evidence of these modalities.
Methods: Embase, Pubmed and the Cochrane database were searched on 13 February 2017. Diagnostic
accuracy studies taking post-surgical seizure outcome as reference standard were selected. Quality
appraisal was based on the QUADAS-2 framework.
Results: Eleven studies were included: eight MSI (n = 267), three HR-ESI (n = 127) studies. None was free
from bias. This mostly involved: selection of operated patients only, interference of source imaging with
surgical decision, and exclusion of indeterminate results. Summary sensitivity and specificity estimates
were 82% (95% CI: 75–88%) and 53% (95% CI: 37–68%) for overall source imaging, with no statistical dif-
ference between MSI and HR-ESI. Specificity is higher when partially concordant results were included as
non-concordant (p < 0.05). Inclusion of indeterminate test results as non-concordant lowered sensitivity
(p < 0.05).therlands.
846 B.E. Mouthaan et al. / Clinical Neurophysiology 130 (2019) 845–855Conclusions: Source imaging has a relatively high sensitivity but low specificity for identification of the
epileptogenic zone.
Significance: We need higher quality studies allowing unbiased test evaluation to determine the added
value and diagnostic accuracy of source imaging in the presurgical workup of refractory focal epilepsy.
 2019 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights
reserved.1. Introduction
Epilepsy surgery can be a curative treatment option in
patients with refractory focal epilepsy. Success of surgery
depends on accurate delineation of the epileptogenic zone (EZ).
The EZ is a theoretical construct describing the minimum
volume of cortical tissue, that is responsible for generation of
habitual seizures, and that has to be resected to produce
seizure-freedom (Luders et al., 2006). Clinical semiology, imaging
and electrophysiological data yield important localizing informa-
tion about the EZ. Video-EEG monitoring (vEEG), magnetic
resonance imaging (MRI), positron emission tomography (PET),
single photon emission tomography (SPECT) and intracranial
EEG (iEEG) are frequently used modalities in the presurgical
workup (Jayakar et al., 2014).
High resolution electric source imaging (HR-ESI) and magnetic
source imaging (MSI) are additional electrophysiological tech-
niques to non-invasively localize epileptogenic brain regions. By
reconstructing the electric or magnetic potentials as identified by
EEG or MEG, locations of underlying source currents are estimated
and subsequently combined with structural imaging. Source local-
ization is often based on interictal epileptic discharges (IED), which
are frequently observed during EEG or MEG recording. Because
IEDs mark the irritative zone and may not always be concordant
with the seizure onset zone (Alarcon et al., 1994; Hirsch et al.,
1991), source localization based on ictal data has been proposed
in patients with high seizure frequency (Boon et al., 2002;
Eliashiv et al., 2002; Pillai and Sperling, 2006; Nemtsas et al.,
2017). So far most experience has been acquired with interictal
ESI and MSI, but complete clinical integration across all epilepsy
surgery centers has not been established yet (Bagic, 2011;
Mouthaan et al., 2016; Stefan and Trinka, 2017). A number of
epilepsy-specific clinical practice guidelines and general recom-
mendations have been published (Bagic et al., 2009, 2011; Leijten
and Huiskamp, 2008; Andre-Obadia et al., 2015). Yet, disparities
in current practice among users on aspects such as the number
and positions of sensors, and the selection of inverse and volume
conduction models remain (Bagic, 2011; Mouthaan et al., 2016).
This may be due to the various technical complex and non-
intuitive aspects involved in source localization (Brodbeck et al.,
2010). MSI and HR-ESI appear to be complementary techniques
that differ in their sensitivity for various neural generators: funda-
mentally MSI is more accurate than ESI in detecting superficial tan-
gentially orientated sources and involves no signal distortion
(volume conduction) while EEG allows recording of all source ori-
entations, is more sensitive to deep sources and is less affected by
motion artefacts (Mégevand and Vulliémoz, 2013). One previous
systematic review on MSI reported that there is insufficient evi-
dence on the use of MSI in the presurgical evaluation (Lau et al.,
2008). This review did not evaluate HR-ESI and was published
nearly a decade ago. In light of the E-PILEPSY network [http://
www.e-pilepsy.eu], which aims to harmonize and optimize presur-
gical diagnostic procedures across European countries, we carried
out a systematic review to assess the diagnostic accuracy of inter-
ictal HR-ESI and MSI to localize epileptogenic regions of interest in
epilepsy surgery candidates.2. Methods
2.1. Establishment of task force and protocol
As a first step we conducted a broad literature search to allow
an orientation on the available literature. Based on this, we estab-
lished a systematic review protocol containing research questions
and study inclusion criteria. A task force was formed of 14 E-
PILEPSY members (corresponding co-authors) to allow a broad
acceptance of the systematic review protocol and to aid other
review tasks (e.g. paper screening, data extraction). Members were
familiar with both the field of source imaging and epilepsy surgery,
having different educational backgrounds (physicists and physi-
cians) and varying experience (PhD students to professors). Con-
sensus was reached among task force members on the final
systematic review protocol.
2.2. Search strategy
PubMed, Embase and Cochrane were last searched on 13 Febru-
ary 2017 for articles on the diagnostic value of EEG and MEG
source localization in epilepsy. We included synonyms and abbre-
viations for the terms of interest, and used subject headings (i.e.
MeSH, EmTree). The search syntaxes are provided in Appendix A.
The search strategy was limited to humans, English language,
and publication date after 1995. Duplicates were eliminated.
2.3. Study selection
Title and abstract screening of the studies was done by one of
two author couples (BM &MR, GH & FL). Discrepancies in eligibility
were discussed and final agreement was reached through a con-
sensus meeting. References found in source imaging review papers
were screened. Studies were excluded if there was insufficient
information to fully assess their eligibility (e.g. full text not avail-
able in English, unavailable abstract, unavailable full text). Letters,
commentaries, conference abstracts, poster presentations and
supplementary materials were also excluded, as were articles
focusing on epilepsy not amenable to surgery (i.e. rolandic epilepsy
or idiopathic generalized epilepsy), and EEG-fMRI. Other
procedures, such as connectivity analysis (Burgess, 2011; van
Dellen et al., 2014), source volume estimation (Bouet et al.,
2012), beta-band activity source imaging (Heers et al., 2014), slow
wave interictal MSI (Ishibashi et al., 2002) and analysis of high
frequency oscillations (van Klink et al., 2016), were not subject of
the review due to their limited clinical utilization compared to
traditional interictal source imaging.
Studies were then screened on full text by couples of two inde-
pendent taskforce members. Full text inclusion criteria were: epi-
lepsy surgery candidates, interictal MSI or interictal ESI,
diagnostic accuracy based on level of concordance between ESI
or MSI source location and the resected area taking seizure out-
come as reference standard.
We consulted authors in the case of unavailable full-text. Stud-
ies needed to report on sensitivity or specificity including confi-
dence intervals and/or absolute numbers that allow calculation
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The full eligibility checklist is provided in Appendix B. Disagree-
ment was discussed and final agreement was reached between
the members of each couple before they submitted their full text
screening results.2.4. Critical appraisal and data extraction
An online quality appraisal and data extraction form was cre-
ated that was first piloted before use. Studies were assessed for
methodological quality against modified QUADAS-2 (quality
assessment of diagnostic accuracy studies) criteria (Whiting
et al., 2011). Certain aspects of the QUADAS-2 framework were
thought to be irrelevant and thus left out from the quality apprai-
sal, such as avoidance of disease progression bias. Results between
reviewers of a couple were compared and, if necessary, a web-
meeting or email conversation was initiated with a third person
to resolve disagreement.
Studies were excluded during data extraction in the case of: 1-
sample size less than 10 participants, 2-patients included with less
than 6 months follow up, 3-not categorizing surgical outcome by
means of Engel (Engel et al., 1993) or ILAE classification (Wieser
et al., 2001), 4-no classification of concordant and non-
concordant ESI or MSI results, 5-low resolution ESI (<64 channels),
6-not presenting results for low resolution (<64 channels) and high
resolution (64 channels) ESI separately, 7-absence of patients in
any of the four groups of the 2  2 contingency table (i.e. zero
values).2.5. Data analysis
We considered diagnostic accuracy as the ability of source
localization (HR-ESI or MSI) to detect and localize an epileptogenic
source within a brain region that is subsequently validated as
epileptogenic based on resection and surgical outcome. Concor-
dance between source location and resected volume was consid-
ered as ‘test positive’ and may represent source localization
within resection volume or sublobar co-localization of the source
estimate with resection volume. Non-concordance was defined as
‘test negative’. Post-surgical outcome was taken as reference stan-
dard, discriminating between good and poor surgical outcome
(Fig. 1).Fig. 1. Diagnostic accuracy 2  2 contingency table for source localization. Concordant:
volume. Sensitivity: true positives/ (true positives + false negatives). Good surgical outcom
results: e.g. too low number of IEDs, artefacts. Specificity: true negatives/(true negati
concordant or non-concordant group affects sensitivity and specificity. Allocation of indetIn accordance with most studies, sensitivity was defined as the
proportion of good-outcome patients with concordant classifica-
tion (i.e. test positive), relative to the total number of good-
outcome patients. Specificity was defined as the proportion of
poor-outcome patients with non-concordant classification (i.e. test
negative), relative to the total number of poor-outcome patients.
Positive and negative predictive values (PPV, NPV) were not
considered in this study. Since the proportion of patients with
either non-localizing source localization results, or those not pro-
ceeding to surgery after source localization procedure, was
unknown in most studies the calculation of positive and negative
predictive values was deemed unreliable. Moreover, predictive val-
ues are expected to vary strongly among studies due to different
presurgical workup strategies (comprehensive versus limited
workup), surgical strategies (liberal versus conservative resection)
and patient characteristics (e.g. lesional versus non-lesional, TLE
versus ETLE). Results from patients undergoing hemispherectomy,
hemispherotomy, or re-resection (second stage surgery) were
excluded from analysis.
To establish homogeneity among studies, we defined ‘‘good
outcome” as Engel I or ILAE 1-2. Results from studies classifying
Engel II or ILAE 3 as good outcome were manually corrected to
our proposed definition, if data was provided. If not, the definition
as proposed in the study was adopted. For studies quantitatively
reporting level of overlap between resection area and source (e.g.
90% of dipoles within resected area) the dichotomization threshold
as used in the study was selected- discriminating concordant from
non-concordant - to account for the effect of source localization
parameters on threshold definition only known by study authors.
We selected the concordance definition (i.e. sublobar co-
localization or location within resection volume) that the primary
study used for sensitivity and specificity calculation and included
this in our analysis.
Allocation of partially concordant categories theoretically
affects sensitivity and specificity calculations (Fig. 1). For those
studies that provided information, we allocated partially concor-
dant results as normal concordant results to ensure homogeneity
across all studies regarding classification. Patients with multiple
sources (either within one lobe or across multiple lobes) were also
handled as concordant, even when only one source was partially
resected. Indeterminate test results (i.e. no source localization pos-
sible due to insufficient numbers of IEDs, too many artefacts or
scattered sources) were handled as a separate category andMSI or ESI source within resection volume or sublobar concordancy with resection
e: Engel 1/ILAE 1–2. Poor surgical outcome: Engel  2/ILAE  3. Indeterminate test
ves + false positives). Allocation of partially concordant (i.e. partially resected) to
erminate test results tot the non-concordant group affects sensitivity and specificity.
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(Cohen et al., 2016; Shinkins et al., 2013).
We calculated mean proportions (including 95% confidence
intervals) for good-surgical outcome in each concordance group
using a weighted binary random-effects model. We calculated a
summary estimate of sensitivity and specificity by means of the
bivariate linear mixed model by Reitsma to account for the two-
dimensional trade-off between sensitivity and specificity
(Reitsma et al., 2005; Gatsonis and Paliwal, 2006). Subgroup anal-
ysis was performed for the selection of studies that provided surgi-
cal outcome information for indeterminate and partial
concordance test results. Subgroup analysis for epilepsy location
(TLE versus ETLE) and MRI results (lesional versus non-lesional)
was performed. Statistical programming was done using the
program Open-Meta Analyst and the mada package used in .R
(R Development Core Team, 2008; Doebler, 2015).3. Results
3.1. Study selection
Fig. 2 visualizes the flow of studies through the review process.
Our search yielded 1964 papers after removal of duplicates. After
title/abstract screening 96 papers were selected for full text assess-
ment.Reference checkingof reviewpapers revealed twonewstudies.
Fifty one studies proceeded to data extraction and quality appraisal,Fig. 2. Flow of studies throf which twelve were prospective. Seven of these were excluded for
reason of different study objectives (n = 5) (Carrette, De Tiege, et al.,
2011; Knowlton et al., 2009; Wu et al., 2010; Knowlton et al., 2006;
De Tiege et al., 2012), not concerning the population of interest
(n = 1) (Assaf et al., 2004) or for not using a reference standard of
interest (Widjaja et al., 2013). In total, forty studies were excluded
during data extraction (see Appendix C for list of excluded studies
in this phase and their exclusion reasons). This led to a total of 11
studies that were included in the review: eight on MSI, three on
HR-ESI (Jeong, Chung, and Kim 2012; Kim et al., 2013; Schneider
et al., 2012; Wilenius et al., 2013; Papanicolaou et al., 2005; Mu
et al., 2014; Knowlton et al., 2008; Almubarak et al., 2014;
Brodbeck et al., 2011; Megevand et al., 2014; Feng et al., 2016).
3.2. Study characteristics
All studies were cross-sectional cohort studies, of which five
were prospective (Table 1). The number of included patients with
positive source localization (sample size) ranged from 14 to 52
(median 36). Seven studies reported the proportion of patients
with indeterminate test results: one HR-ESI study (16%) and six
MSI studies (7–36%, median 17%). Four of these six MSI studies
additionally provided surgical outcome results for this group
(Jeong et al., 2012; Knowlton et al., 2008; Wilenius et al., 2013;
Mu et al., 2014).
Three studies reported that indeterminate test results may be
resulting from their source localization procedure but did not spec-ough review process.
Table 1
A: adult; EZ: epileptogenic zone; (F) CD: (focal) cortical dysplasia; MLR: multi-lobar resection; P: paediatric; SLR: single lobe resection; SR: surgical resection sim EEG:
simultaneously recorded EEG; a: one patient with scattered source result excluded; b: eight second stage surgery patients excluded; c: surgical outcome for partial concordance
category provided; d: insufficient details on Engel classification to reclassify; e: nine patients with scattered source results excluded, 9 patients with repeated surgery excluded f:
two thresholds reported by study (10% and 25%), highest threshold selected by reviewers; g: patients with less than 6 months follow-up excluded h: type of source estimate (e.g.
single dipoles, clusters) not specified. i: study classifies partially/non-concordant results with poor outcome as indeterminate test result. For data analysis purposes these were
considered true negatives by reviewers; j:post-op MRI available, but study did not report its role in resection volume estimation; k: thirteen indeterminate test results excluded;
l: 6/38 did not undergo surgery and were excluded; m: When one of the solution points directly neighbouring the source maximum was inside the resection volume, this was
considered concordant.
Study Data
collection
Sample
size
Age
group
Population
characteristics
Type
of test
Type of
resective
surgery
%
multiclusters
Resection
volume
estimation
Study’s
concordance
definition
Minimum
follow up
(years)
Good
outcome
definition
Jeong et al.
(2012)
Retrospective 24a A FCD
(histologically
confirmed)
MEG
(+sim
EEG)
SLR (23),
MLR (1)
50 Post-op
MRI
Complete or
partial cluster
resection
1 Engel 1
Kim et al.
(2013)
Retrospective 14b P Neocortical
epilepsy
MEG
(+sim
EEG)
SLR (13),
MLR(1)
79 Post-op
MRI
>70% of all
dipoles within
resection
volume
1 Engel 1
Schneider
et al.
(2012)
Retrospective 18 A + P Neocortical MRI
negative epilepsy
MEG
(+sim
EEG)
SLR (16),
MLR (2)
39 Post-op
MRI
Complete or
partial resection
of unifocal
clusterc
2 Engel 1ad
Wilenius
et al.
(2013)
Retrospective 16e A + P FCD
(histologically
confirmed)
MEG SLR (14),
MLR(2)
6 Post-op
MRI
>25% of source
clusters within
resection
volumef
0,5 Engel 1g
Papanicolaou
et al.
(2005)
Prospective 41 A + P Mixed group MEG
(+sim
EEG)
Not
specified
unclear Not
specified
Complete
source estimate
resectionc,h,i
1 ILAE class
1–2
Mu et al.
(2014)
Retrospective 38 A + P FLE MEG Not
specified
24 Not
specifiedj
Complete
cluster
resectionc
0,5 Engel 1
Knowlton
et al.
(2008)
Prospective 49k A + P Inconclusively
localizing MRI
and vEEG with
seizures recorded
on ICEEG
MEG
(+sim
EEG)
Not
specified
Unclear Not
specified
Sublobar co-
localization of
cluster and
resection
volume
1 Engel 1
Almubarak
et al.
(2014)
Retrospective 36 A + P Mixed group
with localizing
ICEEG
MEG
(+sim
EEG)
Not
specified
Unclear Post-op
MRI
Complete
cluster
resection
0,5 Engel 1ad
Brodbeck
et al.
(2011)
Prospective 52 A + P Mixed group HR-
EEG
SLR (41),
MLR(11)
NA Not
specified
Complete
source
maximum
resection
1 Engel 1
Megevand
et al.
(2014)
Prospective 32l A + P Mixed group, all
underwent ICEEG
HR-
EEG
Not
specified
NA Post-op
MRI
Complete
source
maximum
resectionm
1 Engel 1
Feng et al.
(2016)
Prospective 43 A + P TLE which did
not require ICEEG
HR-
EEG
Not
specified
NA Post-op
MRI
Sublobar co-
localization of
source
maximum and
resection
volume
0,58 Engel
1–2d
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2012; Papanicolaou et al., 2005; Feng et al., 2016). One study did
not mention indeterminate test results at all (Brodbeck et al.,
2011).
Regarding population characteristics, one study focused on
adults, one on children, and nine included both age groups. Inclu-
sion criteria varied among studies. Indications to perform ESI or
MSI were not always explicitly stated, but could be derived
from inclusion criteria. Five studies provided information
whether resection included single lobe or multiple lobes for each
patient.
Seven studies used post-operative MRI to assess the resection
volume. Three studies did not mention use of post-op MRI. One
study reported that post-op MRI was available, but did not further
specify if this was applied to assess resection volume (Mu et al.,
2014). Concordance with resection volume was defined as sublo-
bar by two and as ‘source estimate within resection volume’ by
nine studies.Concordance definition varied among studies. Six studies spec-
ified how partially concordant results were handled. Three studies
separately reported surgical outcome for patients with partially
concordant results (Schneider et al., 2012; Papanicolaou et al.,
2005; Mu et al., 2014). Three studies did not: two included patients
with partial concordance in the complete concordance group
(Jeong et al., 2012; Megevand et al., 2014), and one considered this
as non-concordant (Almubarak et al., 2014). Multifocal source esti-
mates were reported by five MSI studies; their occurrence ranged
between 6% and 79% (median, 39%) of the patients (Jeong et al.,
2012; Kim et al., 2013; Schneider et al., 2012; Wilenius et al.,
2013; Mu et al., 2014). Three studies classified resection of only
one source in a multifocal source patient as concordant. One study
classified such cases as non-concordant. One study presented data
for multi-cluster cases but did not state its classification, and was
therefore considered non-concordant by our reviewers.
All but one study used Engel class to define outcome. Definition
of good outcome varied between Engel 1a and Engel 1–2. Mini-
850 B.E. Mouthaan et al. / Clinical Neurophysiology 130 (2019) 845–855mum follow up period ranged from 6 months to one year. Study
duration ranged between 2–11 years.
All HR-ESI studies used sensor nets with whole-head coverage
consisting of 128-256 EEG electrodes. One study used a realistic
head model (FDM) (Feng et al., 2016) and two a spherical head
model (SMAC) (Brodbeck et al., 2011; Megevand et al., 2014). Lin-
ear distributed inverse solution based on averaged spikes was used
in all studies. One used LORETA (Feng et al., 2016), one LAURA
(Brodbeck et al., 2011) and one used an unspecified distributed
inverse solution (Megevand et al., 2014).
All MSI studies used whole-head MEG. In one study the applied
technique varied between double-probe (74 channels) and whole-
head (306 channels) MEG (Mu et al., 2014). Six out of eight studies
used simultaneous EEG to aid IED identification. No averaging was
performed in any study. All studies used equivalent current dipole
(ECD) as inverse solution. Overall, cluster definition varied among
studies.3.3. Methodological quality
Study quality was generally assessed as ‘‘poor” according to
QUADAS-2; no study was free from bias (Table 2). Studies scored
badly on disease spectrum bias, partial verification bias and inap-
propriate exclusions from data analysis. All studies enrolled a con-
secutive sample of patients, none were of case-control design.
Selection bias (i.e. disease spectrum bias) was applicable to
eight studies. This was the case for studies selecting specific pop-
ulations such as patients undergoing or not undergoing intracra-
nial EEG, patients with frontal lobe epilepsy or patients with
histologically proven focal cortical dysplasia. A consequence of
our inclusion criteria was an additional general disease spectrum
bias across all studies. It was believed that exclusion of patients
that were considered non-eligible for surgery based on presurgi-
cal workup, most likely resulted in an over-estimation of diagnos-
tic accuracy. We did not visualize this in the quality summary to
permit between-study difference in selection bias to be
noticeable.
One study was biased for the index test based on data-driven
threshold selection (Wilenius et al., 2013). Two retrospective stud-
ies did not report information on blinding from reference standard
information, and were judged as unclear for index test bias.
Reference standard bias was observed in five studies. Good sur-
gical outcome was defined as only Engel 1a by two studies
(Schneider et al., 2012; Almubarak et al., 2014) or only Engel 1–2
by one (Feng et al., 2016). Three studies included patients with fol-
low up period between 6–12 months (Mu et al., 2014; Almubarak
et al., 2014; Feng et al., 2016). Two studies classified concordance
based on sublobar co-localization (Knowlton et al., 2008; Feng
et al., 2016).Table 2
Quality appraisal of individual studies. low risk, high risk, unclear risk.
Type of test Study Risk of bias
Patient
selection
Index test Reference
standard
MSI Jeong et al. (2012)
Kim et al. (2013)
Schneider et al. (2012)
Wilenius et al. (2013)
Papanicolaou et al. (2005)
Mu et al. (2014)
Knowlton et al. (2008)
Almubarak et al. (2014)
HR-ESI Brodbeck et al. (2011)
Megevand et al. (2014)
Feng et al. (2016)Bias regarding study flow was observed in ten studies. In six
studies, source localization results were considered in the decision
to proceed to surgery (partial verification bias), the decision for
coverage/placement of ICEEG, or the area/extend of resection (dif-
ferential verification bias) (Schneider et al., 2012; Wilenius et al.,
2013; Mu et al., 2014; Knowlton et al., 2008; Almubarak et al.,
2014; Feng et al., 2016; Kim et al., 2013). Six studies did not report
surgical outcome data for indeterminate test results (Jeong et al.,
2012; Schneider et al., 2012; Papanicolaou et al., 2005;
Almubarak et al., 2014; Feng et al., 2016; Kim et al., 2013). All fac-
tors possibly led to over-optimistic diagnostic accuracy. Insuffi-
cient data was reported by one study to permit bias judgment
(Brodbeck et al., 2011).
Variations among studies with respect to population, index test
specifics, and reference standard specifics were not considered a
concern regarding applicability as all these represented part of
general clinical practice.3.4. Diagnostic accuracy
Diagnostic accuracy analysis of MSI and ESI accuracy included a
total of 394 patients, 267 on MSI and 127 on HR-ESI, of whom sur-
gical outcome data was available. In 363 patients a localizing
source was found: 236 MSI and 127 HR-ESI (Fig. 3). For all MSI
studies, good surgical outcome was reached in 130/236 patients
(mean: 54%, 95% CI: 45–63%). For HR-ESI this was 86/127 patients
(mean: 67% 95% CI 49–85%). No statistical difference on the prob-
ability of good surgical outcome between MSI and HR-ESI studies
was observed.
In total, the number of patients with good surgical outcome in
the concordant group was higher (172/226 patients, mean: 76%,
95% CI: 67–86%) than the number of patients in the non-
concordant group (36/111 patients, mean: 28%, 95% CI: 19–36%).
Statistical difference between the concordant and non-
concordant group regarding good surgical outcome probability
was found for MSI and HR-ESI (Table 3).
Surgical outcome data of indeterminate test results was avail-
able in four MSI studies; 18/31 patients (mean 56%, 95% CI:33–
79%) had good surgical outcome. Sensitivity ranged between 50–
96% for MSI and 80–91% for HR-ESI. Specificity ranged between
17–80% for MSI and 56–75% for HR-ESI (Appendix D).
Summary estimates based on the bivariate linear mixed model
showed sensitivity and specificity of 82% (95% CI: 75–88%) and 53%
(95% CI: 37–68%) for overall source localization. For HR-ESI, sum-
mary sensitivity and specificity were 87% (95% CI: 77–93%) and
61% (95% CI: 45–74%) respectively (Fig. 4). For MSI, summary sen-
sitivity and specificity were 79% (95% CI: 69–87%) and 46% (95% CI:
25–70%) respectively. HR-ESI and MSI sensitivity/specificity esti-
mates did not show statistical difference (p > 0.05).Applicability concerns
Flow and timing Patient
selection
Index test Reference
standard
Fig. 3. 2x2 contingency table for patient total in all studies (both MSI and HR-ESI).
Table 3
Odds ratio of level of concordance for surgical outcome. HR-ESI: High resolution electric source imaging. MSI: magnetic source imaging. a: based on studies reporting surgical
outcome for partially concordant cases, three MSI studies in total.
Concordance category per type of test Good surgical outcome probability in patients (mean, 95% CI) Odds ratio 95% Confidence interval P-value
HR-ESI
Concordant 75/91 (82%, 67–98%) 9.6 3.8–24.0 <0.001
Partially concordant Not applicable – – –
Non-concordant 11/36 (30%, 15–45%) Ref – –
MSI
Concordant 97/135 patients (74%, 63–85%) 4.7 1.7–12.9 0.002
Partially concordanta 8/26 patients (30%, 12–47%) 1.7 0.35–8.4 0.512
Non-concordant 25/74 patients (25%, 13–37%) Ref – –
Fig. 4. Summary ROC curve with summary estimates for HR-ESI (red) and MSI
(blue). Individual studies are shown as small symbols. Summary points shown as
large symbols, representing sensitivity and specificity estimates pooled using the
bivariate linear mixed model. The 95% CI is represented by dotted line (—). (For
interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
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locations were based on five MSI studies and were 83% (95% CI:
63–93%) and 22% (95% CI: 20–72%) respectively. No statistical dif-ferences regarding sensitivity and specificity estimates were
observed when multifocal sources were included in the estimation
(Appendix E). Analysis for the allocation of partially concordant
results was based on three studies. A statistically significant higher
specificity estimate was observed when partially concordant
results were categorized as non-concordant, compared to concor-
dant categorization (69% versus 20%, p < 0.05). Based on four stud-
ies reporting surgical outcome of patients with indeterminate
source imaging results, statistically significant lower summary
sensitivity was observed when indeterminate test results were
included in the estimates and considered non-concordant (61%
versus 76%, p < 0.05).
Subgroup analysis showed good surgical outcome in 11/14
lesional patients (mean: 80%, 95% CI: 61–99%) and 46/68 non-
lesional patients (mean: 60%, 95% CI: 43–85%) with concordant
results. For non-concordant results these were 2/12 in lesional
patients (mean: 16%, 95% CI: 1–34%) and 8/18 in non-lesional
patients (mean: 42%, 95% CI: 19–66%). Summary sensitivity for
lesional and non-lesional patients was similar, and specificity
showed now apparent difference (p = 0.059, Appendix E).
Subgroup analysis for lobar location showed that a good surgi-
cal outcome was achieved in 64/96 TLE patients (mean: 61%, 95%
CI: 33–89%) and 47/92 ETLE patients (mean: 43%, 95% CI: 21–
65%) with concordant results. Good surgical outcome was achieved
in 9/24 TLE patients (mean: 37%, 95% CI: 19–54%) and 12/34 in
ETLE patients (mean: 42%, 95% CI: 16–68%) of the non-
concordant group. Summary sensitivity and specificity for TLE
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cant differences were observed (Appendix E).4. Discussion
Electric and magnetic source localization are believed to be
valuable techniques in the diagnostic workup of epilepsy surgery
candidates. We performed a systematic review and included eight
studies on MSI and three on HR-ESI that used seizure outcome
after surgery as a reference standard. All studies were highly
biased on various aspects, with considerable heterogeneity among
studies regarding the included population and test methodology.
Bivariate meta-analysis estimated a summary sensitivity and
specificity of 82% (95% CI: 75–88%) and 53% (95% CI: 37–68%) for
overall source localization and no statistical difference between
HR-ESI and MSI was found.
The only previous systematic review on source localization
included more studies (17 in total) and reported a higher MSI sen-
sitivity (84% versus 79%) and higher specificity (52% versus 46%)
than our study (Lau et al., 2008). Separate pooling of sensitivity
and specificity permitted authors to include more studies, even
when sensitivity or specificity measures were missing in individual
studies due to zero values in the 2  2 contingency tables. How-
ever, separate pooling of sensitivity and specificity fails to account
for the trade-off between these two measures, the more so when
either one is not calculable for all studies. Therefore, we decided
to include only studies without zero values in the 2  2 contin-
gency tables and calculated sensitivity and specificity by means
of bivariate modelling, at the cost of the number of included stud-
ies (Deeks, 2001; Macaskill et al., 2010). Other outcomes also pro-
vide information on the clinical value of a test; of which several
have been published for MEG. Changes in clinical management
after MEG following previous conventional non-invasive presurgi-
cal workup, were seen in 21–35% of patients, in whom 11–75% of
these changes were considered as crucial or of clear impact (De
Tiege et al., 2012; Stefan et al., 2003). In 23–33% of surgical candi-
dates who required ICEEG, a change in clinical management after
MEG was observed, of which 26–39% was classified ‘beneficial’
according to the authors (Sutherling et al., 2008; Knowlton et al.,
2009). The level to which clinical management is changed by HR-
ESI remains uncertain as such studies were not discovered by our
literature search.
Heterogeneity among studies regarding the included popula-
tion was observed. It has been proposed that MSI and ESI should
preferentially be applied in extratemporal rather than temporal
lobe epilepsy, as - in the latter - an epileptic focus may easily prop-
agate through a well-developed and complex limbic network, lead-
ing to a more wide-spread irritative zone (Leijten and Huiskamp,
2008; Vadera et al., 2013). None of the individual studies reported
statistical differences in test performance between temporal,
extratemporal, lesional and non-lesional epilepsy patients, which
was also not found by our pooled subgroup analysis
(Papanicolaou et al., 2005; Brodbeck et al., 2011; Megevand
et al., 2014).
The underreporting of surgical outcome data for patients with
indeterminate source imaging results, and the inconsistency in
reporting partially concordant results, were an important finding
of our study. Indeterminate test results were more frequently
reported in MSI studies (six studies) than in HR-ESI studies (one
study). Unexpectedly, the majority of patients with indeterminate
MSI test results had good outcome. The importance of these results
was highlighted; a statistically significant lower sensitivity was
observed when indeterminate test results were included in the
analysis of diagnostic accuracy. We further showed that categoriz-
ing partially concordant results as non-concordant significantlyaffects specificity. An explorative analysis showed a statistically
significant higher sensitivity for HR-ESI over MSI only when inde-
terminate test results and partially concordant results were calcu-
lated as non-concordant. HR-ESI studies showed, as compared to
MSI studies, a very low number of indeterminate and partially con-
cordant results, and they were all prospective and based on dis-
tributed inverse methods. Therefore, this result is likely
confounded and therefore not reported as a definite result. As
addressed by Papanicolaou and colleagues, cases of partial concor-
dance between source estimate and resected area do not have the
same significance as cases of complete or non-concordance
(Papanicolaou et al., 2008). In the context of other imaging modal-
ities, partially concordant results may be clinically valuable.
The ability to record epileptic activity from deep midline struc-
tures (e.g. mesial temporal regions) is much debated, as such mea-
sures are hampered by cortical propagation and relative low signal
compared to background brain activity (Knowlton, 2006; Koessler
et al., 2015; Carrette, Op de Beeck, et al., 2011; Gavaret et al., 2004).
It often occurs that source localization records only the neocorti-
cally (anterio-temporal) propagated hippocampal spikes, not the
hippocampal spikes themselves. As surgical strategy aims to resect
the underlying hippocampal pathology, the source localization
result are left out of the resection volume. From a strict localization
perspective, such spatially distinct source solutions do not con-
tribute to identification of the true EZ over other possible EZ’s.
The high variation among studies on dealing with such results calls
for consensus within the community (Schneider et al., 2013).
Our study has several limitations. First, strict inclusion criteria
resulted in few primary studies. A higher number of MSI studies
was found compared to HR-ESI and the number of MSI patients
outnumbered those with HR-ESI (267 versus 127) reflecting the
novelty of HR-ESI relative to MSI.
Second, the quality appraisal was mostly designed for illustra-
tive purposes and the degree to which each quality domain con-
tributes to over- or underestimation of diagnostic accuracy is not
quantified. Yet, it is certain that our self-induced patient selection
bias, resulting from not taking into account patients who were
rejected after presurgical workup, promotes both MSI and HR-ESI
diagnostic accuracy over-optimistically. When verification bias
(i.e. inclusion of source localization results in the presurgical
workup) is present, diagnostic accuracy is corrupted by clinical
decision making; surgical resection might easily be expanded after
consideration of the source localization results.
Third, inclusion criteria were restricted to ESI studies using 64
EEG electrodes, as this is considered to be the minimum number
of channels necessary for accurate localization (Leijten and
Huiskamp, 2008; Lantz et al., 2003; Sohrabpour et al., 2015). Yet,
several studies on surgical candidacy have applied ESI based on
more widely clinical available long term EEG systems and report
sensitivity and specificity ranging between 50–62% and 17–50%
(Coutin-Churchman et al., 2012; Oliva et al., 2010). The number
of electrodes should not be considered the sole criterion. Adequate
coverage of the head, especially inferior temporal regions, is of
importance. Although this was not an inclusion criteria, all of our
included HR-ESI studies used whole-head electrode coverages,
including subtemporal regions therefore improving localization
accuracy (Rosenzweig et al., 2014; Seeck et al., 2017; Bach
Justesen et al., 2018).
We further excluded studies that did not dichotomize their
results into concordance categories. A large difference between
dichotomization thresholds was observed in the studies by Wile-
nius et al., and Kim et al., (25% versus 70%) (Kim et al., 2013;
Wilenius et al., 2013). This proves that a manual dichotomization
would have probably disregarded methodological considerations
that are often familiar only to those involved in the source localiza-
tion procedure, and on which threshold selection generally is
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2008). In many of the studies there was underreporting on techni-
cal specifics such as artefact handling, spike criteria and selection
of the spike interval. Such specifics are important to allow ade-
quate interpretation of study results. Liberal spike criteria and
inappropriate artefact handling may be responsible for less accu-
rate localizations. Source localization based on spike peaks have
higher SNR compared to spike onset but could possibly be contam-
inated by propagation effects resulting in different localizations on
sublobar level (Maliia et al., 2016). If such information was avail-
able, subgroup analysis could have aided recommendations on
these technical aspects.
Fourth, surgical outcome as reference standard – though con-
sidered to be the ultimate standard for localization (Knowlton
et al., 2008) – is not free from uncontrollable variables.
The Engel classification does not allow straightforward compar-
ison between epilepsy surgery centers due to its considerable sub-
jective judgement using terms as ‘‘some disabling seizures” and
‘‘worthwhile improvement” in seizure frequency (Wieser et al.,
2001). Neither outcome classification (Engel or ILAE classification)
includes post-surgical use of anti-epileptic drugs. Absolute proof of
removal of the epileptogenic zone might ideally be established by
complete seizure freedom off all anti-epileptic drugs following epi-
lepsy surgery. Further, resection is often limited by eloquent cor-
tex, and seizure recurrence after initial postsurgical seizure
freedom can occur due to newly evolved epileptogenic tissue
(Knowlton et al., 2008; Vadera et al., 2013). The definition of a true
positive is based on the unambiguous proof that resection of a
source estimate results in good surgical outcome. However, an
important issue emerges when we attempt to compare studies
with different definitions of ‘concordant localization’. A first con-
cern is that sublobar regions are defined according to anatomical
landmarks and may differ widely in size and shape depending on
their location and among patients (Megevand et al., 2014). In the
case of resection volume concordance, the resected area can still
be sometimes too large to discriminate between different localiza-
tions, especially for multilobar resections (Wheless et al., 1999). A
second aspect is that the size of the source estimate partly depends
on the quality of the source solution. A liberal acceptance of weak
dipoles with low SNR might result in widespread dipole solutions
or excessive large clusters. Yet, they also might just reflect large
epileptogenic areas. Also, clusters can be defined as a number of
dipoles localized within the same sublobar region (Schneider
et al., 2012; Knowlton et al., 2008; Murakami et al., 2016) or within
a region of fixed dimensions (Wilenius et al., 2013). Specificity
might be even more unreliable: surgical failure does not necessar-
ily rule out epileptogenicity of resected tissue, as a more wide-
spread epileptogenic network can be present (Hauptman and
Mathern, 2012). Also the consideration of a source estimate
beyond the resection volume in cases of surgical failure as a ‘true’
localization is debatable as non-resected areas encompass both
epileptogenic and non-epileptogenic regions, (Rikir et al., 2017).
Although surgical outcome as reference standard might not be
ideal, different reference standards, such as ICEEG (Jung et al.,
2013; Oishi, Kameyama, et al., 2006; Oishi, Otsubo, et al., 2006;
Otsubo et al., 2001; Tenney et al., 2014; Knowlton et al., 2006;
Agirre-Arrizubieta et al., 2009; Ossenblok et al., 2007), MRI lesion
(Morioka et al., 1999; Stefan et al., 2011; Michel et al., 2004) or pre-
sumed EZ (Knowlton et al., 1997) suffer from limitations as well. It
is known that peri-lesional areas are often marked as epileptogenic
and good surgical outcome might not always necessitate complete
removal of the SOZ (Mu et al., 2014; Plummer et al., 2008). The pre-
sumed EZ remains a theoretical construct up to the point of resec-
tion (Mu et al., 2014; Plummer et al., 2008).
Considering all issues discussed above, future diagnostic accu-
racy studies require improvements on bias and transparency.Investigators may use the Standards for Reporting of Diagnostic
Accuracy checklist for their study (Shinkins et al., 2013; Cohen
et al., 2016; Bossuyt et al., 2015). Emphasis should be given on
prospective study designs, and cohorts should include all patients
in whom presurgical source localization procedures are performed
and apply alternative reference standards (e.g. seizure onset zone
based on ICEEG, lesion location) on those not eventually submitted
for surgery. Ideally, decisions to proceed to surgery and the area of
resection should be independent from source localization results,
but is probably unethical. As an alternative, the presurgical team
may be exposed to the source imaging results after they have made
the initial decision on surgery so that the influence on clinical deci-
sion making can be accounted for to a maximum degree. A normal-
ization algorithm, which accounts for resection size, source
estimation size, and differences in procedural approaches should
be developed to allow fair comparison between patients and stud-
ies. EEG and MEG contain complementary information due to their
distinct technical properties. Its combined use is demonstrated to
have superior diagnostic accuracy over use of ESI or MSI alone
(Chowdhury et al., 2018). More studies are needed to further
explore the accuracy and feasibility of EEG-MEG fusion source
localization (Aydin et al., 2015).
Once an appropriate level of diagnostic accuracy is established,
the integrative approach of HR-ESI and MSI within the presurgical
workup should be studied by evaluating various combinations
with other tests (e.g. MRI with HR-ESI, MSI with PET) (Lascano
et al., 2016) and which patient groups (e.g. non-lesional, multile-
sional) benefit most.
In this systematic review and meta-analysis, diagnostic accu-
racy of MSI and HR-ESI to localize the epileptogenic regions of
interest is strongly affected by poor study quality and likely biased
towards an overestimation of diagnostic accuracy. Results from
HR-ESI and MSI should therefore be interpreted with caution and
independent support from other diagnostic tools is required to pro-
ceed to resective surgery. High quality studies, that allow unbiased
MSI and ESI evaluation and judge results in light of source estimate
size and resection size are needed to obtain high quality evidence.
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